COVID-19 BIOWEAPON

COVID-19 BIOWEAPON

I asked myself several questions.
WHY is the current CoVID-19 coronavirus (SARS-Cov-2) so powerful, and so virulent?
WHY does it preferentially seek out people who have high ACE2 docking sites on their cells due to their prescription medicines or diseases, obesity, smoking?
WHY does it cause tremendous immune system dysfunction in many infected people, similar to what we see with AIDS patients? 
And Who funded this?

INFLAMMATION NOT LDL

INFLAMMATION NOT LDL

At a medical conference I asked a Chairman of Medicine of a prestigious university how he would treat a man who had a massive heart attack with a cholesterol of only 140, LDL of 50, normal coronary arteries, and no other risk factors.  He said ‘That’s a no brainer – give him a high dose statin.’  I then said, “That man’s cholesterol, LDL and coronary arteries are excellent.  It’s probably only inflammation or a clot, so one could use vitamins and other nutrients instead.”  He abruptly and arrogantly said ‘No, give him a statin’ and he turned away.  This is what Big Pharma does.  They pay so-called “thought leaders” to influence other doctors to prescribe their drugs. And these “thought leaders” must not deviate from the written words given to them by Big Pharma.

LOW LDL DOES NOT PROTECT, BUT BIG PHARMA AND HARVARD SAY YES

Amgen, the maker of evolocumab (Repatha) funded the research, paid EVERY author on the paper, led by Harvard researchers, and the findings were published in the prestigious New England Journal of Medicine May 4, 2017. If you take the drug, evolocumab (Repatha), your LDL will go down but you won’t live any longer. IT’S ALL ABOUT INFLAMMATION AND OXIDATION.

COVID-19 BIOWEAPON

COVID-19 BIOWEAPON

I asked myself several questions.
WHY is the current CoVID-19 coronavirus (SARS-Cov-2) so powerful, and so virulent?
WHY does it preferentially seek out people who have high ACE2 docking sites on their cells due to their prescription medicines or diseases, obesity, smoking?
WHY does it cause tremendous immune system dysfunction in many infected people, similar to what we see with AIDS patients? 
And Who funded this?